Genentech Biosimilar Suit Tossed After Just 2 Weeks
A Delaware federal judge on Wednesday wiped out Genentech's newly filed lawsuit accusing Amgen of improperly concealing information about a proposed biosimilar of cancer drug Avastin, finding that the complaint isn't...To view the full article, register now.
Already a subscriber? Click here to view full article